YTYoshinori Takei

Yoshinori Takei

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yoshinori Takei has a total of 31 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Photostimulable Phosphor Glass for Ionizing Radiation Monitoring

    by Hidehito Nanto, Kazuki Hirasawa, Yoshinori Takei, Yuka Yanagida, Yoshihiro Koguchi, Takayoshi Yamamoto

    Silver (Ag+) doped phosphate glass after exposure to ionizing radiation has an intense luminescence by stimulating with ultra-violet light. This phenomenon is called radiophotoluminescence (RPL). The RPL intensity was increased linearly with increasing X-ray irradiation dose up to about 1000 Gy. Small amount of bead-type RPL glass as large as about 0.05mm was well prepared with a jet flame system. It was confirmed that the RPL glass beads could be used as passive-type radiation dosimeters. Visualization and monitoring system of radiation dose distribution utilizing RPL phenomenon in the Ag+-doped phosphate glass are developed in this study. In the presentation, the basic luminescence properties are reported as well as the application of Ag+-doped phosphate glass beads to radiation dose distribution monitoring.

  • Sequential Updating of The Error Covariance Matrix in Subspace Identification for Time-varying System

    by Y. Takei, H. Nanto, S. Kanae, Z.J. Yang, K. Wada

    Recursive updating algorithms of error covariance matrices in subspace identification methods for time-varying systems are derived. The proposed algorithms can be applied to estimate the system parameters which are slowly time-varying. The algorithms are based on the fact that the subspace extraction amounts to computing singular value decomposition of the SC of the input submatrix in data product moments and the SC can be interpreted as the least squares residuals. We have proposed an unified framework for the MOESP type of the subspace identification method by using the SC. In this paper, we show the aforementioned time-varying case can be also treated in the proposed framework.


  • Recursive Subspace Identification Using A Unified Approach

    by Y. Takei, H. Nanto, S. Kanae, Z.J. Yang, K. Wada

    Using a unified approach, recursive subspace identification algorithms are derived for the MOESP type of subspace methods. The proposed approach is based on the fact that the subspace extraction amounts to computing singular value decomposition of the Schur complement (SC) of the input submatrix in data product moments and the SC can be interpreted as the least squares residuals.

  • Open Access

    A Unified Approach for Subspace Identification Algorithms

    by Y. Takei, H. Nanto, S. Kanae, Z.J. Yang, K. Wada

    In this paper, a unified approach for subspace-based identification methods by using Schur complement is proposed. MOESP (MIMO output error state space model identification) type of subspace idenitification methods are well known as an elementary subspace method. The extensions of the MOESP with instrumental variables (IV) have been proposed, which can be useful to solve the stochastic identification problems. We consider data product moments corresponding to the data matrix in the MOESP algorithms, then we show that the IV matrices in the MOESP-based methods can be expressed as modifications of the data product moment, and it enable us to treat the IV-MOESP algorithms under a unified framework even if the errors-in-variables (EIV) problems are considered.

  • Open Access

    Subspace Identification for Errors-in-Variables Models using Schur Complement Approach

    by Y. Takei, H. Nanto, S. Kanae, Z. J. Yang, K. Wada

    In this paper, an interpretation of subspace-based identification methods with Schur complement approach is proposed. MOESP (MIMO output error state space model identification) algorithms are well known as an elementary subspace method. The extensions of the MOESP with instrumental variables (IV) have been proposed in literatures, which can be useful to solve the stochastic identification problems. Data product moments corresponding to the data matrix in the MOESP algorithms are used. Then we show that the IV extensions in the MOESP-based methods can be expressed as modifications of the data product moment, and it enable us to treat the MOESP-based algorithms under a same framework even if the errors-in-variables (EIV) problems are considered.


    • 1 February 2000
      • Vol. 40  (2) , 140-4

    [A case of polymyositis presenting pregnancy with acute respiratory failure].

    by S Ishikawa, Y Takei, T Maruyama, S Koyama, N Hanyu

    A 33-year-old pregnant woman developed respiratory difficulty with bilateral pleural effusion 31 weeks into gestation. On admission she had an elevated serum level of creatine kinase, but muscle weakness in the extremities was mild. After an immediate and successful Cesarean section, she developed respiratory failure and mechanical ventilation was required. The patient was diagnosed as having polymyositis from the limb muscle biopsy. She was treated with dexamethasone at a dose of 8 mg, methylprednisolone++, 1 g daily for three days, and then prednisolone 60 mg daily. One week later the serum level of creatine kinase was normalized and the patient was weaned from ventilator support. The dose of prednisolone was tapered 10 mg every week and she was discharged two months after delivery without prednisolone. A chest CT scan revealed no interstitial pneumonitis or aspiration pneumonia, so her respiratory failure seemed to be ascribable to polymyositis-related respiratory muscle weakness and pleural effusion. However, severe involvement of respiratory muscles without generalized marked muscle weakness is extremely rare, and pleural complications have usually been described in association with pulmonary parenchymal diseases. During the following two years polymyositis has not recurred in this patient and there have been no data indicative of other overlapping collagen diseases. Reports of polymyositis which occurred during pregnancy are rare, and the pathogenesis and clinical outcome of these patients need to be carefully investigated.


  • Determination of bradykinin-(1–5) in inflammatory exudate by a new ELISA as a reliable indicator of bradykinin generation

    by M. Majima, K. Nishiyama, Y. Iguchi, K. Yao, M. Ogino, T. Ohno, N. Sunahara, K. Katoh, N. Tatemichi, Y. Takei, et al.

    We have developed an ELISA for BK-(1–5) (Arg1-Pro2-Pro3-Gly4-Phe5). In rat carrageenin-induced pleurisy, in which a plasma exudation peak was observed 5 h after carrageenin, BK levels in the exudates were negligible (8-Arg9-BK) was detectable (900–400 pg/rat) over the entire course of the inflammation. However, a larger amount of BK-(1–5) was detectable in association with the increase in plasma exudation, showing a peak (8800±1200 pg/rat) 3 h after carrageenin. Bromelain (10 mg/kg, i.v.) and soy bean trypsin inhibitor (0.3 mg/rat, intra-pleural) significantly reduced BK-(1–5) levels (by 60–93%, 3, 7 and 19 h after carrageenin) and plasma exudation rates (by 61–74%, 3 and 7 h after carrageenin). Dexamethasone (0.3 mg/kg, i.p.) reduced BK-(1–5) levels (by 78%) and decreased plasma exudation (by 70%) 3 h after carrageenin. In nasal allergy patients, antigen challenge of nasal mucosa elevated BK-(1–5) levels and active kallikrein levels in nasal washes. These results verify that BK-(1–5) determined by ELISA is a good indicator for release of kinins in vivo.


    • 1 February 1994
      • Vol. 21  (2) , 249-54

    [5-Fluorouracil plus low-dose leucovorin in the treatment of advanced colorectal cancer].

    by H Shida, K Ban, M Matsumoto, Y Takei, Y Noda, K Masuda, T Imanari, T Machida, T Yamamoto

    From September 1989 to September 1992, 17 patients (pts) with non-curative or recurrent colorectal cancer were treated with 5-fluorouracil (FU) plus leucovorin (LV) systemic therapy. The sites of evaluable metastases were liver (10), peritoneum (4), lung (3) and others (6). The LV dosage was 30 mg/body (low-dose method) and the FU dosage was 500-750 mg/body. Both drugs were administered either 5 days/every 4 weeks or one day/every 1 to 2 weeks via protracted or bolus infusion. The regimen was generally well tolerated, although 9 pts (53%) experienced toxicity which required dose reductions. Overall response rate was 29% (5 PR). No CR was observed. Improvement in tumor-related symptoms was noted temporarily in 7 out of 10 pts. Serum CEA level decreased in 13 out of 14 pts. All the response sites were liver (5), with simultaneous lung (1) or peritoneum (1) metastasis. The response duration was 3 to 10 months (mean 6.2 months). Second-line therapy after progression of diseases, such as combination with CDDP, was attempted in some of the PR pts, but no re-response was observed. We conclude that FU plus low-dose LV regimen is an effective therapy for advanced colorectal cancer, but further attempts should be made to increase response rate, prolongation of response duration and effective second-line therapy after progression.